Navigation Links
Michael J. Fox Foundation Announces Launch of PD Online Research

-- New Web-based community will increase collaboration and resource-sharing in global PD scientific community --

NEW YORK, June 1 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research announced the launch of PD Online Research (, a resource-rich virtual workplace that MJFF hopes will become a vibrant Web-based community of PD researchers and funders collaborating and conversing across the globe. MJFF's goal in developing the site is simple: quicker knowledge turns and therefore faster progress in developing transformative new therapies for people with Parkinson's disease.

PD Online is a direct outgrowth of the MJFF's awareness that its own convening power -- which brings together hundreds of research professionals at scores of in-person meetings every year -- is in many ways as important to research progress as is its funding. "Extending the incredibly productive and efficient interactions we see at our meetings to the Web via a scientific social/professional network will provide a platform for thousands of research professionals across the world. It will let them engage daily on key hurdles and hot topics, hopefully accelerating progress and breakthroughs in PD drug development," said Katie Hood, CEO of the MJFF.

The site, which has been conceptualized and built by MJFF in collaboration with Massachusetts General Hospital and the Initiative in Innovative Computing at Harvard University, is a one-stop shop for both an overview of the state of Parkinson's disease research as well as deep dives into top therapeutic targets and technical issues. The Foundation also hopes PDOR will help drive even better decision-making about PD research investment, helping public, nonprofit and private PD investors access a larger pool of experts than ever before, and in the process make smart and timely decisions about the research paths they choose to pursue.

Key content elements of PDOR include:

  • PD Guide -- a continuously updated Parkinson's disease information model that seamlessly delivers all relevant information contained within the site based on users' paths through the content
  • PD Biblio -- a compendium of PD papers in the scientific literature annotated with members' commentary and debate on the authors' assumptions, arguments, and outcomes
  • Virtual Workspaces -- members are free to form or join groups that serve as virtual collaboration hubs within a laboratory or institution, or beyond institutional borders with PD Online members around the world interested in a particular topic
  • Comprehensive listings of funding opportunities and scientific events in PD research and related fields

PD Online Research content is offered as a free resource to the general public. But since MJFF's primary focus is on building a technical hub for Parkinson's research, only scientists, clinicians, allied healthcare professionals directly engaged in scientific research, and investment decision-makers interested in Parkinson's disease in the public, nonprofit, and private sectors will have the ability to post directly to the site. Other interested parties, including people with Parkinson's and their families and members of the general public, will have the ability to read content and discussions and are invited to submit ideas and questions about PD science and therapeutic development to the PD Online team, who will add this input to the PD Online mix where it can help drive discussion and debate forward.

"PD Online will be successful if we can develop a committed and active community all tied to the same goal of accelerating a cure," said Gene Johnson, PhD, chief scientific advisor to MJFF. "But community members really need to believe in the value of the site not only for the greater good, but for their own work. We believe this is possible given the quality of the platform we've developed, and we're excited to see how the community evolves and speeds progress going forward."

To learn more, visit

The Michael J. Fox Foundation is dedicated to ensuring the development of better treatments, and ultimately a cure, for Parkinson's disease through an aggressively funded research agenda. MJFF has funded over $142 million in research to date. Learn more at

    Media Contact: Holly Barkhymer
    (212) 509-0995 x242

    Research Contact: Michael T. Rogan, PhD
    (212) 509-0995 x273

SOURCE Michael J. Fox Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NPC Newsmaker Program Hosts Briefing on Health Care Reform with Former HHS Secretary Michael Leavitt and Former Senate Majority Leader Tom Daschle
2. Michael Ward Cited for Support of Wounded Warrior Project
3. Majesco Entertainment and Interactive Game Group Announce Two New Jillian Michaels Fitness Video Games
4. Prematics Names S. Michael Ross Chief Medical Officer and Senior Vice President of Business Development
5. Michael J. Fox Foundation Announces $2 Million Funding Commitment to Drive Development of Parkinsons Disease Biomarker Pipeline
6. Celebrated Architect Michael Graves to Keynote HEALTHCARE DESIGN.09 Conference
7. Aleres Dr. Michael Taitel Provides Insights Into Reducing Health and Productivity Costs During Turbulent Economic Times
8. Dr. Michael B. Cates Takes Leadership Role on AVMAs One Health Joint Steering Committee
9. NeuroFocus Appoints Dr. Michael Smith as Partner in Consulting Practice
10. Sigma-Aldrich Announces Appointment of Michael Kanan as Vice President and Corporate Controller
11. J. Michael Cook to Retire from Lilly Board of Directors
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new Android app ... new app features a more intuitive SleepScore™ that rates sleep quality on a 100-point ... SleepScore is created by a proprietary algorithm. Beddit analyzes the data to provide an ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, ... from Bronx, N.Y. “I thought there had to be a convenient and comfortable way ... , The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for ... The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout 2016 ...
(Date:11/25/2015)... ... 25, 2015 , ... An unlikely combination of recycled plastic ... for homeless people to have a more dignified and comfortable night’s sleep. , ... are repurposing plastic bags into sleeping mats for the homeless. The project, ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has focused on providing comprehensive solutions involving adult stem cell therapies to patients ... officially deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Trovagene, Inc. (NASDAQ: ... announced that Chief Executive Officer Antonius Schuh, Ph.D., is ... th Annual Piper Jaffray Healthcare Conference. ... New York Palace Hotel in New York ... p.m. EST. Mr. Schuh will be available for one-on-one ...
(Date:11/25/2015)... Nov. 25, 2015 Endo International plc (NASDAQ: ... Silva , President and CEO, will discuss corporate updates at ... New York on Wednesday, December 2, ... Click on Investor Relations, and then the link to the ... presentation,s start time to visit the site and download any ...
(Date:11/25/2015)... November 25, 2015 Asia ... to which BioLight and the New Investors will make ... ("IOPtima") via a private placement. The financing will help ... IOPtimate™ system used in the treatment of glaucoma, as ... for the IOPtimate™ system with the U.S. Food and ...
Breaking Medicine Technology: